Skip to main content

Icotrokinra vs Pentosan Polysulfate

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Icotrokinra is primarily a immune support peptide, while Pentosan Polysulfate is used for healing & recovery.

This page compares Icotrokinra and Pentosan Polysulfate across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

IcotrokinraPentosan Polysulfate
CategoryImmune SupportHealing & Recovery
Regulatory status (US)FDA approvedFDA approved
Typical dosage—300 mg
Frequency—daily
Reported benefits—Joint protection, cartilage health, anti-inflammatory, bladder health
Reported side effects—Possible GI upset, hair loss (rare)

Key differences

Primary use. Icotrokinra is categorised under Immune Support, while Pentosan Polysulfate falls under Healing & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Icotrokinra: FDA-approved. Pentosan Polysulfate: FDA-approved.

Dosing. Typical dosing for Icotrokinra is not catalogued. Pentosan Polysulfate is typically dosed at 300 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Icotrokinra and Pentosan Polysulfate has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Icotrokinra and Pentosan Polysulfate?
Icotrokinra is primarily a immune support peptide, while Pentosan Polysulfate is used for healing & recovery. Icotrokinra is FDA-approved for one or more indications, whereas Pentosan Polysulfate is FDA-approved for one or more indications.
What is Icotrokinra used for?
Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
What is Pentosan Polysulfate used for?
FDA-approved oral drug (ELMIRON) for bladder pain of interstitial cystitis; joint uses are investigational.
Can you take Icotrokinra and Pentosan Polysulfate together?
Some users combine peptides within a single protocol, but stacking Icotrokinra and Pentosan Polysulfate has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Icotrokinra or Pentosan Polysulfate FDA-approved?
Icotrokinra is FDA-approved for one or more indications. Pentosan Polysulfate is FDA-approved for one or more indications.

Read the full articles

More Immune Support comparisons

Icotrokinra compared across categories

← All peptide comparisons